CytomX Therapeutics (NASDAQ:CTMX) Shares Gap Up After Analyst Upgrade

CytomX Therapeutics, Inc. (NASDAQ: CTMX - Get Free Report) gapped up prior to trading on Thursday after Barclays raised their price target on the stock from $10.00 to $16.00. The stock had previously closed at $4.40, but opened at $4.51. Barclays currently has an overweight rating on the stock. CytomX Therapeutics shares last traded at $4.8370,